Back
Emerson Electric 10K Form
Buy
74
EMR
Emerson Electric
Last Price:
132.78
Seasonality Move:
3.26%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-08 | 10Q | EMR/Emerson Electric Quarterly |
2024-02-07 | 10Q | EMR/Emerson Electric Quarterly |
2023-11-13 | 10K | EMR/Emerson Electric Annual |
2023-08-02 | 10Q | EMR/Emerson Electric Quarterly |
2023-05-03 | 10Q | EMR/Emerson Electric Quarterly |
2023-02-08 | 10Q | EMR/Emerson Electric Quarterly |
Receive EMR News And Ratings
See the #1 stock for the next 7 days that we like better than EMR
EMR Financial Statistics
Sales & Book Value
Annual Sales: | $17.49B |
---|---|
Cash Flow: | $916M |
Price / Cash Flow: | 26.16 |
Annual Sales: | $37.94 |
Price / Book: | 3.5 |
Profitability
EPS (TTM): | 3.42000 |
---|---|
Net Income (TTM): | $1.97B |
Gross Margin: | $8.89B |
Return on Equity: | 7.34% |
Return on Assets: | 4.36% |
Emerson Electric Earnings Forecast
Key Emerson Electric Financial Ratios
- The Gross Profit Margin over the past 41 years for EMR is 50.79%.
- The Selling, General & Administrative Expenses for EMR have been equal to 29.40% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 16.41% of Operating Income.
- The Net Earning history of EMR is 11.25% of Total Revenues.
- Per Share Earnings over the last 41 years have been positive in 32 years.
Emerson Electric Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | S&P500 |
---|---|
Industry: | Electrical Equipment |
Sector: | Industrials |
Current Symbol: | EMR |
CUSIP: | 291011 |
Website: | emerson.com |
Debt
Debt-to-Equity Ratio: | 0.36 |
---|---|
Current Ratio: | 1.78 |
Quick Ratio: | 1.13 |
Price-to-Earnings
Trailing P/E Ratio: | 38.7 |
---|---|
Forward P/E Ratio: | 20.47 |
EMR Technical Analysis vs Fundamental Analysis
Buy
74
Emerson Electric (EMR)
is a Buy
Is Emerson Electric a Buy or a Sell?
-
Emerson Electric stock is rated a Buy
The current Emerson Electric [EMR] share price is $132.75. The Score for EMR is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.